Attached files

file filename
EX-23.2 - EX-23.2 - Oak Street Health, Inc.d128690dex232.htm
EX-23.1 - EX-23.1 - Oak Street Health, Inc.d128690dex231.htm

As filed with the Securities and Exchange Commission on February 10, 2021

No. 333-                

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

Oak Street Health, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   8000   84-3446686

(State or other jurisdiction of incorporation

or organization)

 

(Primary Standard Industrial

Classification Code Number)

  (I.R.S. Employer Identification No.)

30 W. Monroe Street

Suite 1200

Chicago, Illinois 60603

Telephone: (312) 733-9730

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Mike Pykosz

Chief Executive Officer

30 W. Monroe Street

Suite 1200

Chicago, Illinois 60603

Telephone: (312) 733-9730

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies of all communications, including communications sent to agent for service, should be sent to:

 

Robert M. Hayward, P.C.

Robert E. Goedert, P.C.
Michael P. Keeley
Kirkland & Ellis LLP
300 North LaSalle

Chicago, IL 60654
(312) 862-2000

 

Michael Kaplan

Pedro J. Bermeo

Davis Polk & Wardwell LLP

450 Lexington Avenue

New York, New York 10017

(212) 450-4000

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.

 

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box:  ☐

If this Form is filed to registered additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☒ File Number 333-252843

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of

Securities to be Registered

 

Amount

to be
Registered(1)

  Proposed
Maximum
Offering Price
Per Share
 

Proposed
Maximum
Aggregate

Offering Price(1)(2)

 

Amount of

Registration Fee

Common stock, par value $0.001 per share

  1,982,394   $56   $111,014,064   $12,111.63

 

 

(1)

Includes 258,573 shares subject to the underwriters’ option to purchase additional shares. The shares being registered under this Registration Statement are in addition to the 10,350,000 shares registered pursuant to the Registration Statement on Form S-1 (File No. 333-252843).

(2)

Calculated pursuant to Rule 457(a) under the Securities Act of 1933, as amended, for the purpose of determining the registration fee based on the public offering price per share of $56. The registrant previously registered securities with a proposed maximum aggregate offering price not to exceed $555,070,500 on the Registration Statement on Form S-1 (File No. 333-252843), which was declared effective by the Securities and Exchange Commission on February 8, 2021 In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $111,014,064 are hereby registered.

 

 

This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) promulgated under the Securities Act.

 

 

 


 

 

 

EXPLANATORY NOTE AND INCORPORATION OF

CERTAIN INFORMATION BY REFERENCE

This Registration Statement on Form S-1 is being filed with respect to the registration of additional shares of common stock, par value $0.001 per share, of Oak Street Health, Inc., a Delaware corporation, pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This Registration Statement includes the registration statement facing page, this page, the signature page, an exhibit index, an opinion of counsel regarding the legality of the securities being registered and a related consent and accountants’ consent. This Registration Statement relates to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-252843), initially filed by the Registrant on February 8, 2021, declared effective by the Securities and Exchange Commission on February 10, 2021. The Registrant is filing this Registration Statement for the sole purpose of increasing the aggregate number of shares of common stock offered by the selling shareholders by 1,982,394 shares, which includes 258,573 additional shares that the underwriters have the option to purchase. Pursuant to Rule 462(b), the contents of the Registration Statement on Form S-1 (File No. 333-252843), including the exhibits and the power of attorney thereto, are incorporated by reference into this Registration Statement.



SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Chicago, State of Illinois, on February 10, 2021.

 

OAK STREET HEALTH, INC.
By:  

/s/ Mike Pykosz

  Name:   Mike Pykosz
  Title:   Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Mike Pykosz

   Chief Executive Officer and Director   February 10, 2021
Mike Pykosz    (Principal Executive Officer)

/s/ Timothy Cook

   Chief Financial Officer   February 10, 2021
Timothy Cook    (Principal Financial and Accounting Officer)

*

   Chief Operating Officer and Director   February 10, 2021
Geoff Price   

*

   Chief Medical Officer and Director   February 10, 2021
Griffin Myers   

*

   Director   February 10, 2021
Regina Benjamin

*

   Director   February 10, 2021
Carl Daley

*

   Director   February 10, 2021
Cheryl Dorsey

*

   Director   February 10, 2021
Mohit Kaushal

*

   Director   February 10, 2021
Kim Keck

*

   Director   February 10, 2021
Julie Klapstein

*

   Director  
Paul Kusserow


Signature

  

Title

 

Date

*

   Director   February 10, 2021
Robbert Vorhoff     

*

   Director   February 10, 2021
Srdjan Vukovic     

 

  

 

*

The undersigned, by signing his name hereto, signs and executes this Registration Statement pursuant to the Powers of Attorney executed by the above named signatories and previously filed with the Securities and Exchange Commission on February 8, 2021.

 

/s/Rob Guenthner

Rob Guenthner
Attorney-in-fact